Literature DB >> 3007495

A possible role for glucose metabolites in the regulation of inositol-1,4,5-trisphosphate 5-phosphomonoesterase activity in pancreatic islets.

R S Rana, M C Sekar, L E Hokin, M J MacDonald.   

Abstract

Rat pancreatic islets demonstrate inositol-1,4,5-trisphosphate 5-phosphomonoesterase activity which is 3 times higher than that in the exocrine pancreas. This enzyme has several features in common with the erythrocyte and hepatocyte enzymes: it is located primarily in the plasma membrane, it has a similar Km for inositol trisphosphate (IP3) (16 microM), and it requires Mg2+. The activity of the islet enzyme is inhibited by several diphosphorylated glucose metabolites: 2,3-bisphosphoglycerate, fructose 1,6-bisphosphate, fructose 2,6-bisphosphate, and glucose 1,6-bisphosphate. Monophosphorylated and unphosphorylated metabolites have little or no effect on its activity. Several reports show that stimulation of islets with glucose raises the concentrations of various glucose metabolites including fructose 1,6-bisphosphate, glucose 1,6-bisphosphate, and 2,3-bisphosphoglycerate to concentrations that are in the range that inhibit the islet inositol-1,4,5-trisphosphate 5-phosphomonoesterase. Other reports show that IP3 mobilizes calcium when added to permeabilized insulin-secreting cells. It is possible that the increase in cytosolic calcium known to occur during glucose-induced insulin secretion may be sustained in part by higher IP3 levels resulting from the inhibition of inositol-1,4,5-trisphosphate 5-phosphomonoesterase by some of the diphosphorylated glucose metabolites.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3007495

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  The dephosphorylation pathway of D-myo-inositol 1,3,4,5-tetrakisphosphate in rat brain.

Authors:  C Erneux; A Delvaux; C Moreau; J E Dumont
Journal:  Biochem J       Date:  1987-11-01       Impact factor: 3.857

2.  Inositol 1,4,5-trisphosphate binds to a specific receptor and releases microsomal calcium in the anterior pituitary gland.

Authors:  G Guillemette; T Balla; A J Baukal; K J Catt
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

3.  Preferential localization of rat liver D-myo-inositol 1,4,5-trisphosphate/1,3,4,5-tetrakisphosphate 5-phosphatase in bile-canalicular plasma membrane and 'late' endosomal vesicles.

Authors:  S B Shears; W H Evans; C J Kirk; R H Michell
Journal:  Biochem J       Date:  1988-12-01       Impact factor: 3.857

Review 4.  Metabolism of the inositol phosphates produced upon receptor activation.

Authors:  S B Shears
Journal:  Biochem J       Date:  1989-06-01       Impact factor: 3.857

5.  D-myo-inositol 1,4,5-trisphosphate phosphatase in skeletal muscle.

Authors:  D Milani; P Volpe; T Pozzan
Journal:  Biochem J       Date:  1988-09-01       Impact factor: 3.857

6.  Simultaneous oscillations of cytoplasmic free Ca2+ concentration and Ins(1,4,5)P3 concentration in mouse pancreatic beta-cells.

Authors:  C J Barker; T Nilsson; C J Kirk; R H Michell; P O Berggren
Journal:  Biochem J       Date:  1994-01-15       Impact factor: 3.857

7.  Inositol tetrakisphosphate liberates stored Ca2+ in Xenopus oocytes and facilitates responses to inositol trisphosphate.

Authors:  I Parker; I Ivorra
Journal:  J Physiol       Date:  1991-02       Impact factor: 5.182

Review 8.  Aspects of novel sites of regulation of the insulin stimulus-secretion coupling in normal and diabetic pancreatic islets.

Authors:  A Sjöholm
Journal:  Endocrine       Date:  1998-08       Impact factor: 3.633

9.  Depolarization-induced influx of sodium in response to phenylephrine in rat atrial heart muscle.

Authors:  U Jahnel; H Nawrath; E Carmeliet; J Vereecke
Journal:  J Physiol       Date:  1991-01       Impact factor: 5.182

10.  Masses of inositol phosphates in resting and tetanically stimulated vertebrate skeletal muscles.

Authors:  G W Mayr; R Thieleczek
Journal:  Biochem J       Date:  1991-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.